ESC 365 - The impact of genetic mutations on ventricular tachycardia substrate types and ablation outcome in patients with non ischemic cardiomyopathy

EHRA Premium Access

The impact of genetic mutations on ventricular tachycardia substrate types and ablation outcome in patients with non ischemic cardiomyopathy

Session: Young Investigator Awards - Clinical

Topic: Ventricular Arrhythmias and SCD - Epidemiology, Prognosis, Outcome

Speaker: Doctor M. Ebert (Dresden, DE)

Event: EHRA 2018

Congress Presentation

Add to my library

About the speaker

Doctor Micaela Ebert

Heart Center - University Hospital Dresden, Dresden (Germany)

11 presentations

2 followers

5 more presentations in this session

Outcomes of a nationwide screening program for silent arrythmogenic cardiovascular disease in young individuals

Speaker: Doctor H. Dhutia (Leicester, GB)

Risk of sudden infant death syndrome (SIDS) among siblings of SIDS victims: a Danish nationwide cohort study

Speaker: Doctor C. Glinge (Copenhagen, DK)

Are recurrences of post MI VT due to substrate progression of insufficient index ablation? A 4 years FU study

Speaker: Doctor A. Lam (Zurich, CH)

Wide area left atrial appendage isolation for atrial fibrillation therapy: Long-term succes and incidence of stroke and thrombus formation

Speaker: Doctor C. Heeger (Hamburg, DE)

Whole human heart histology to evaluate the performance of bipolar and unipolar voltage mapping in the detection of fibrosis in patients with non-ischemic cardiomyopathy and ventricular tachycardia

Speaker: Ms C. Glashan (Leiden, NL)

Access the full session

Young Investigator Awards - Clinical

Speakers: Doctor M. Ebert, Doctor H. Dhutia, Doctor C. Glinge, Doctor A. Lam, Doctor C. Heeger...

About the event

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources